Biased detection of guanine-rich microRNAs by array profiling: Systematic error or biological phenomenon?

Abstract This article describes an unexpected phenomenon which was revealed during the study of microRNA expression profiles of breast tumors. Hierarchical clustering has distinguished two broad groups of microRNAs with different expression patterns. One of these groups, Group Q (“questionable”), was composed mainly of recently discovered microRNAs and contained a large number of viral microRNA species. This microRNA subset was found to be extremely rich in guanine. The above features suggest that the Group Q is an artifact of microRNA expression profiling. However, the latter explanation is not supported by the evidence for biologically relevant associations observed for the Group Q microRNAs.

[1]  Michael W. Pfaffl,et al.  Normalization Strategies for Microrna Profiling Experiments: a 'normal' Way to a Hidden Layer of Complexity? , 2010 .

[2]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[3]  Leonard D. Goldstein,et al.  MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype , 2007, Genome Biology.

[4]  Lisa A Carey,et al.  Understanding and treating triple-negative breast cancer. , 2008, Oncology.

[5]  Pauline E. Chugh,et al.  Potential pitfalls in microRNA profiling , 2012, Wiley interdisciplinary reviews. RNA.

[6]  Tongbin Li,et al.  Drosha processing controls the specificity and efficiency of global microRNA expression. , 2011, Biochimica et biophysica acta.

[7]  Israel Steinfeld,et al.  miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors , 2011, PloS one.

[8]  Y. Miki,et al.  High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas , 2012, Breast Cancer Research and Treatment.

[9]  J. Baak,et al.  Biologic profiling of lymph node negative breast cancers by means of microRNA expression , 2010, Modern Pathology.

[10]  S. Knuutila,et al.  MicroRNA microarrays on archive bone marrow core biopsies of leukemias--method validation. , 2011, Leukemia research.

[11]  G. Hannon,et al.  The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response , 2009, Proceedings of the National Academy of Sciences.

[12]  H. Moine,et al.  G‐quadruplexes in RNA biology , 2012, Wiley interdisciplinary reviews. RNA.

[13]  N. Palanisamy,et al.  Genomic Loss of miR-486 Regulates Tumor Progression and the OLFM4 Antiapoptotic Factor in Gastric Cancer , 2011, Clinical Cancer Research.

[14]  F. Zhao,et al.  Small RNA transcriptome investigation based on next-generation sequencing technology. , 2011, Journal of genetics and genomics = Yi chuan xue bao.

[15]  L. De Cecco,et al.  Comparison of Microarray Platforms for Measuring Differential MicroRNA Expression in Paired Normal/Cancer Colon Tissues , 2012, PloS one.

[16]  R. Irizarry,et al.  Performance evaluation of commercial miRNA expression array platforms , 2010, BMC Research Notes.

[17]  Z. Yakhini,et al.  Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue , 2011, Molecular oncology.

[18]  R. Ach,et al.  Direct and sensitive miRNA profiling from low-input total RNA. , 2006, RNA.

[19]  Paul Bertone,et al.  Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. , 2010, RNA.

[20]  Frédéric Lemoine,et al.  Concordance among digital gene expression, microarrays, and qPCR when measuring differential expression of microRNAs. , 2010, BioTechniques.

[21]  R. Ach,et al.  Measuring microRNAs: Comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods , 2008, BMC biotechnology.

[22]  R. Shafer,et al.  Biological aspects of DNA/RNA quadruplexes , 2000, Biopolymers.

[23]  A. Malpertuy,et al.  Comparative analysis of missing value imputation methods to improve clustering and interpretation of microarray experiments , 2010, BMC Genomics.